J

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076

Watchlist Manager
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
Watchlist
Price: 48.17 CNY 0.25% Market Closed
Market Cap: 10.6B CNY

Intrinsic Value

The intrinsic value of one Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock under the Base Case scenario is 102.65 CNY. Compared to the current market price of 48.17 CNY, Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd is Undervalued by 53%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
102.65 CNY
Undervaluation 53%
Intrinsic Value
Price
J
Worst Case
Base Case
Best Case

Valuation History
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
CN
Pharmaceuticals
Market Cap
10.6B CNY
IPO
May 20, 2021
CN
Pharmaceuticals
Market Cap
10.6B CNY
IPO
May 20, 2021
Price
ÂĄfalse
EPS
ÂĄfalse
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Current Assets 1.8B
Cash & Short-Term Investments 661.5m
Receivables 565.6m
Other Current Assets 604.2m
Non-Current Assets 2.6B
Long-Term Investments 205.3m
PP&E 1.6B
Intangibles 333.1m
Other Non-Current Assets 490.3m
Efficiency

Free Cash Flow Analysis
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Revenue
1.6B CNY
Cost of Revenue
-518.3m CNY
Gross Profit
1.1B CNY
Operating Expenses
-580.2m CNY
Operating Income
477.9m CNY
Other Expenses
-56.4m CNY
Net Income
421.5m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
60/100
Profitability
Score

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
67/100
Solvency
Score

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Wall Street analysts forecast Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd is 71.6 CNY with a low forecast of 70.9 CNY and a high forecast of 73.71 CNY.

Lowest
Price Target
70.9 CNY
47% Upside
Average
Price Target
71.6 CNY
49% Upside
Highest
Price Target
73.71 CNY
53% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock?

The intrinsic value of one Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock under the Base Case scenario is 102.65 CNY.

Is Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 48.17 CNY, Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd is Undervalued by 53%.

Back to Top